- Home
- Olmetrack CT 12.5 Tablet
Olmetrack CT 12.5 Tablet Substitute
Olmetrack CT 12.5 Tablet Substitute
Verified Ingredients and Effects
Composition:
CHLORTHALIDONE-12.5MG + OLMESARTAN-20MG
Uses:
Olmetrack CT 12.5 Tablet is used in the treatment of Hypertension (high blood pressure). The detailed uses of Olmetrack CT 12.5 Tablet are as follows:<br/>• Treatment of Hypertension: Olmetrack CT 12.5 Tablet is used to treat hypertension by effectively lowering blood pressure through relaxing blood vessels and promoting diuresis.<br/>• Reducing Cardiovascular Risk: By lowering blood pressure, Olmetrack CT 12.5 Tablet helps to reduce the risk of kidney damage, heart failure, heart disease, stroke, and other cardiovascular complications associated with unmanaged hypertension.<br/>
Medicinal Benefits:
Olmetrack CT 12.5 Tablet is a combination of two drugs, namely, Olmesartan (blood pressure-lowering agent) and Chlorthalidone (diuretic), primarily used to treat hypertension (high blood pressure). Olmesartan is an angiotensin receptor blocker (ARB) that lower increased blood pressure by blocking a naturally occurring substance known as angiotensin II (that tightens your blood vessels). It allows these constricted blood vessels to relax and therefore helps lower high blood pressure. This allows the blood to flow more smoothly and the heart to pump more efficiently. On the other hand, Chlorthalidone, a diuretic, works by increasing the amount of urine passed out from the kidneys and lowering blood pressure. Together it lowers the overall raised blood pressure and reduces the risk of having a heart attack, stroke, or kidney problems. Olmetrack CT 12.5 Tablet is generally used when a single medicine is ineffective in controlling blood pressure.
FAQs
Olmetrack CT 12.5 Tablet is used to treat hypertension (high blood pressure).
Olmetrack CT 12.5 Tablet is a combination of two drugs: Olmesartan and Chlorthalidone. Olmesartan belongs to a class of angiotensin receptor blockers that works by relaxing and widening your blood vessels so your blood can flow more easily. This will lower your blood pressure. Chlorthalidone belongs to the class of diuretics that works by increasing urine output, thereby reducing blood pressure.
Olmetrack CT 12.5 Tablet is not recommended in pregnancy. It can affect and harm the baby. Consult your doctor before taking Olmetrack CT 12.5 Tablet if you plan to become pregnant or are already pregnant. Your doctor will weigh the potential risks and benefits before prescribing Olmetrack CT 12.5 Tablet .
High blood pressure is called 'Pregnancy-induced hypertension (PIH). It is harmful to both the baby and the mother. In the mother, very high blood pressure can cause seizures (fits), headache, swelling of feet, kidney damage, and a higher risk of bleeding during pregnancy and delivery. This can also affect the baby by causing abnormal fetal heart rate, risk of stillbirth, and a small baby. So, during pregnancy, you should have regular blood pressure monitoring. Visit your Obstetrician if you have any concerns about blood pressure during pregnancy.
Taking Olmetrack CT 12.5 Tablet may cause dehydration. So, to avoid dehydration, drink plenty of fluids, and inform your doctor if you feel extremely thirsty.
No, you are advised to inform your doctor and monitor your blood pressure for at least two weeks before stopping the medicine. Depending upon your current blood pressure readings, there is a possibility your doctor may lower your medicine dosage and not recommend discontinuing it.
Olmetrack CT 12.5 Tablet can be safely taken as long as your doctor prescribes it. Chronic disease conditions like high blood pressure are life-long conditions, and one should not abruptly discontinue it without discussing it with a doctor.
Olmetrack CT 12.5 Tablet contains chlorthalidone and olmesartan as its active substances. It belongs to a group of medicines called anti-hypertensives.
You may notice a drop in blood pressure within 2 weeks of starting Olmetrack CT 12.5 Tablet , but it can take up to 8 weeks to experience its full benefits. If you have any concerns about Olmetrack CT 12.5 Tablet , consult your doctor. Do not discontinue it without your doctor’s advice.
Olmetrack CT 12.5 Tablet can be taken at any time, but the first dose is often recommended at bedtime to manage dizziness. After that, take it at the same time each day for consistency and effectiveness. Follow your doctor’s instructions.
Yes, you may feel dizzy after taking Olmetrack CT 12.5 Tablet as it is one of its side effects. Avoid driving if you feel dizzy. This condition doesn’t require any medical treatment as it will gradually reduce over time. Consult your doctor, if the condition persists longer.
While using Olmetrack CT 12.5 Tablet , maintain a balanced and nutritious diet rich in vegetables, fruits, whole grains, legumes, omega-3 sources, and lean proteins. Aim for a healthy weight with a BMI between 19.5 and 24.9. Manage stress effectively as chronic stress can elevate blood pressure. Reduce salt intake and limit or avoid alcohol. Quit smoking to reduce the risk of heart disease. If you still have any concerns, discuss with your doctor.
Olmetrack CT 12.5 Tablet may not cause weight gain. However, in rare cases, it may lead to chronic diarrhoea accompanied by significant weight loss. If a patient experiences diarrhoea while using Olmetrack CT 12.5 Tablet and no other cause is identified, the doctor might advise discontinuing the medication and suggest an alternative treatment.
Serious side effects of Olmetrack CT 12.5 Tablet include severe allergic reactions, lightheadedness, kidney dysfunction, electrolyte imbalances, severe diarrhoea and weight loss. Consult your doctor immediately, if you experience any of these symptoms.
There is no particular evidence that shows Olmetrack CT 12.5 Tablet affects fertility in men or women. Therefore, if you experience changes or have any concerns, discuss with your doctor.
Before surgery, inform your doctor if you are using Olmetrack CT 12.5 Tablet . It may need to be discontinued as it can further lower blood pressure when combined with local anaesthesia.